Loading clinical trials...
Loading clinical trials...
50 end-stage renal disease (ESRD) patients whom have had at least 2 doses of messenger ribonucleic acid (mRNA) vaccine, and undergoing transplantation at the University of Alabama at Birmingham (UAB) ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alabama at Birmingham
Collaborators
NCT07531966 · Kidney Transplant Recipient, Kidney Transplant; Complications, and more
NCT06059664 · Kidney Transplant; Complications
NCT07157397 · End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD), and more
NCT06326905 · Quality of Life, Depression, and more
NCT07020832 · Delayed Graft Function, End Stage Renal Disease, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions